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The mechanisms controlling human mesenchymal stem cells (hMSC) diﬀerentiation are not entirely understood. We hypothesized
that the contact with extracellular matrix (ECM) proteins normally found in bone marrow would promote osteogenic diﬀerentiation
of hMSC in vitro. To test this hypothesis, we cultured hMSC on puriﬁed ECM proteins in the presence or absence of soluble
osteogenic supplements, and assayed for the presence of well-established diﬀerentiation markers (production of mineralized matrix,
osteopontin, osteocalcin, collagen I, and alkaline phosphatase expression) over a 16-day time course. We found that hMSC adhere to
ECM proteins with varying aﬃnity (ﬁbronectin > collagen I ≥ collagen IV ≥ vitronectin > laminin-1) and through distinct integrin
receptors. Importantly, the greatest osteogenic diﬀerentiation occurred in cells plated on vitronectin and collagen I and almost no
diﬀerentiation took place on ﬁbronectin or uncoated plates. We conclude that the contact with vitronectin and collagen I promotes
t h eo s t e o g e n i cd i ﬀerentiation of hMSC, and that ECM contact alone may be suﬃcient to induce diﬀerentiation in these cells.
INTRODUCTION
Human mesenchymal stem cells (hMSC) are a popu-
lation of multipotent cells located within the bone mar-
row and are characterized by their ability to diﬀerenti-
ate into at least three phenotypes when cultured in vitro
[1, 2]. These cells are related to, but distinct from, stro-
mal stem cells, and are carefully selected for uniform ex-
pression of approximately 50 surface antigens (with 98%
homogeneity at passage 2), including at least three dif-
ferent stem cell surface marker proteins [1, 2]. Once iso-
lated and puriﬁed from the marrow stroma, uncommit-
ted hMSC retain the capacity to self-renew and diﬀeren-
tiate along multiple pathways resulting in the generation
and maintenance of an assortment of tissues. This in turn
raises the possibility of utilizing these cells to repair or re-
place damaged tissues. A more complete understanding
of the molecular mechanisms driving the diﬀerentiation
of these cells should signiﬁcantly facilitate the adoption of
these cells in clinical applications.
What drives the diﬀerentiation of hMSC is not en-
tirely known. The development of these mesenchymal
progenitors along an osteogenic [3], chondrogenic [4],
and adipogenic [1] linage occurs primarily under the in-
ﬂuence of chemical stimuli (eg, dexamethazone, trans-
forming growth factor β3, insulin), which is accompanied
by profound changes in morphology, proliferation, gene
expression, and molecular signaling events. However, the
underlying mechanisms governing mesenchymal stem
cell diﬀe r e n t i a t i o ni nv i t r oa n di nv i v oa r en o ty e tc o m -
pletely understood.
Cellular diﬀerentiation is induced by cues in the envi-
ronment immediately surrounding cells. Many of the sol-
uble cues known to inﬂuence hMSC diﬀerentiation have
been identiﬁed. For example, when hMSC are cultured
in the presence of ascorbic acid-2-phosphate (AsAP), β-
glycerophosphate(βGP),and thesynthetic glucocorticoid
dexamethasone (Dex), they adopt an osteoblastic phe-
notype and secrete and organize an extracellular matrix
(ECM) where calcium phosphate is deposited as hydrox-
yapatite crystals [5]. Induction by this osteogenic supple-
ment (OS) medium triggers a series of molecular events
including activation of signal transduction pathways and
expression of osteogenic marker genes including collagen
I (COL I), osteocalcin, osteopontin, and alkaline phos-
phatase[1,6,7,8].Whilethesemediasupplementsclearly
induce osteoblast diﬀerentiation under some conditions,
theymaysuppressbonegrowthinvivo[9,10],whichmay
limit their usefulness for repairing bone in situ. Response
to these agents is biphasic, concentration-dependent, and
varies with the length of exposure [6, 11] .T h er e s u l ti sa
somewhat heterogeneous population of cells with mixed
diﬀerentiation potential [12]. There is a clear need to bet-
terunderstandthemolecularmechanismsthatcontrolos-
teogenesis in these cells.
Insoluble cues that aﬀect cellular diﬀerentiation arise
largely from cellular binding to ECM proteins. While
considerable attention has been paid to the role of OS2004:1 (2004) HMSC Diﬀerentiation on Extracellular Matrix 25
Table 1. Primers used for RT-PCR.
GENE/NCBI designation Primer sequences Reference
GAPDH (glyceraldehyde-3-
phosphate dehydrogenase)
Forward 5 -ATGGAAATCCCATCACCATCT-3 
(Doi et al [7])
Reverse 5 -GGTTGAGCACAGGGTACTTTATT-3 
ALPL (alkaline phosphatase) Forward 5 -GACCCTTGACCCCCACAAT-3 
(Frank et al [23])
Reverse 5 -GCTCGTACTGCATGTCCCCT-3 
COL I (collagen type I) Forward 5 -CAGCCGCTTCACCTACAGC-3 
(Frank et al [23])
Reverse 5 -TTTTGTATTCAATCACTGTCTTGCC-3 
SPP1 (osteopontin) Forward 5 -CTCAGGCCAGTTGCAGCC-3 
(Frank et al [23])
Reverse 5 -CAAAAGCAAATCACTGCAATTCTC-3 
BGLAP (bone gamma-carboxyglutamate
(gla) protein/osteocalcin)
Forward 5 -GAAGCCCAGCGGTGCA-3 
(Frank et al [23])
Reverse 5 -CACTACCTCGCTGCCCTCC-3 
medium in hMSC diﬀerentiation, comparatively little is
known about the eﬀect of ECM binding hMSC behavior.
However, it is well known that ECM proteins play a ma-
jor role in bone development. For example, during endo-
chondral bone development, collagen II expression peaks
during the chondrogenesis period while COL I deposi-
tion is maximal during the ossiﬁcation phase [13]. Fur-
thermore, it has been known for decades that single-point
mutations in COL I yield a lethal form of osteogenesis
imperfecta (eg, Pace et al [14]). In other studies, genetic
knockouts of collagen II in mice result in severe devel-
opmental abnormalities and skeletal defects, especially in
cartilaginous elements [15]. In vitro, bone marrow stro-
mal cells undergo osteogenic diﬀerentiation when cul-
tured on COL I matrix, and this requires interaction with
the COL-I-binding integrin α2β1[ 16, 17]. The mecha-
nisms linking ECM binding to osteogenic diﬀerentiation,
especially in hMSC, are largely unknown.
ECM proteins typically aﬀect cell behavior by bind-
ing to speciﬁc integrin cell surface receptors, which ac-
tivate intracellular signaling pathways and control gene
expression, cytoskeletal organization, and cell morphol-
ogy. Over 20 diﬀerent integrin receptors have been iden-
tiﬁed, which bind to well over 20 diﬀerent ECM pro-
teins and stimulate at least six diﬀerent classes of intra-
cellular signaling molecules: protein tyrosine kinases, ser-
ine/threonine kinases, lipid kinases, lipid phosphatases,
protein phosphatases, and intracellular ion ﬂuxes [18].
The contribution of integrin-associated pathways to os-
teogenic diﬀerentiation of hMSC is largely unknown. Re-
centevidenceimplicatesERK1/2,anintegrin-andgrowth
factor-associated signaling protein, as playing a critical
role in osteogenic diﬀerentiation of hMSC in vitro [1].
The role of ECM proteins in controlling ERK 1/2 activ-
ity and other signaling molecules during osteogenesis has
not been investigated.
How hMSC translate adhesion to ECM into cell dif-
ferentiation is entirely unknown. We hypothesized that
adhesion to ECM proteins, in the absence of soluble os-
teogenic stimulants, would enhance the osteogenic diﬀer-
entiation of hMSC. To test this hypothesis, we cultured
hMSC on puriﬁed ECM proteins for 16 days in the pres-
ence or absence of soluble osteogenic supplements and
assessed the diﬀerentiation of these cells by a variety of
markers. Our results demonstrate that contact with COL
Iorvitronectinalonemay besuﬃcient to induce diﬀeren-
tiation in these cells.
MATERIALS AND METHODS
Materials
Puriﬁed bovine COL I, human plasma vitronectin,
and human plasma ﬁbronectin proteins were purchased
from Chemicon International (Temecula, Calif). Puri-
ﬁed mouse collagen IV (COL IV) and mouse laminin-1
proteins were purchased from Collaborative Research Inc
(Bedford, Mass). The α1-6 and β1-4 integrin function-
blocking antibodies (Alpha integrin blocking and IHC
kit, catalog # ECM 430; Beta integrin screening kit, cat-
alog # ECM 440) and anti-human, rabbit IgG antibod-
ies against osteopontin (catalog # AB1870) were obtained
from Chemicon International (Temecula, Calif). Anti-
human, mouse IgG antibody against tubulin was ob-
tained from Sigma (St Louis, Mo) (catalog # T5168).
Phalloidin conjugated to rhodamine (TRITC) was pur-
chased from Molecular Probes (Eugene, Ore). Reverse
transcriptase-polymerase chain reaction RT-PCR primers
listed in Table 1 were purchased from IDT Technologies
(Coralville, Iawa).
CultureofhMSCandhumanosteoblasts
Cryopreserved hMSC were purchased from Cam-
brex Inc (Walkersville, Md) and grown as directed.
Brieﬂy, cells were plated at 5 × 103 cells/cm2 in a
T75 ﬂask (75cm2) for continuous passaging in con-
trol medium (DMEM supplemented with 10% fe-
tal calf serum, 1% L-glutamine [29.2mg/mL], peni-
cillin G [10,000units/mL] and streptomycin sulfate
[10,000µg / m L ] ) .T h eO Sm e d i u mw a sc o n t r o lm e d i u m
(labeled “DMEM” in Figures) supplemented with 0.1µM
Dex, 0.05mM AsAP, and 10mM βGP (Sigma Chemical
Co, St Louis, Mo).
For in vitro osteogenic assays, hMSC were passaged
three times before they were inducted and plated at
densities of 3.1 × 103 cells/cm2 in 0.2mL/cm2 of con-
trol medium in either 60mm Falcon dishes (28.0cm2),26 Roman M. Salasznyk et al 2004:1 (2004)
24-well plates (2.00cm2), or 96-well plates (0.32cm2)a c -
cording to the speciﬁcation of the assays described be-
low. Cultures were incubated at 37◦C in a humidiﬁed at-
mosphere containing 95% air and 5% CO2. The follow-
ing day (day 0), we replaced the culture medium with
OS or fresh control medium. Media changes were per-
formed twice weekly at volumes described above. At days
4, 8, 12, and 16, cultures were assayed as described be-
low.
Isolated human osteoblasts (purchased from Cam-
brex) were grown according to manufacturers’ instruc-
tions in a growth medium (basal medium supplemented
with 10% fetal calf serum, ascorbic acid, gentamycin,
and amphotericin B). Following one week in culture,
cells were replated in growth media supplemented with
200mM hydrocortisone-21-hemisuccinate and 10mM
βGP. Eight days later, cells were harvested and RNA was
isolated for RT-PCR as described below.
Adhesionassays
Cell adhesion assays were performed as previously
described using Sarstedt 96-well suspension cell culture
plates [19]. Tissue culture plates were coated with puri-
ﬁedECMproteins(collagenI+IV,ﬁbronectin,laminin-1,
andvitronectin)ataconcentrationof20µg/mLfor1hour
at room temperature. Wells were washed twice with PBS
and incubated with nd-blotto (5% non-diary creamer in
PBS + 0.2% Tween 20) for 30 minutes prior to the assay.
hMSC were seeded as described above on either plastic
substrata or ECM proteins, and allowed to attach for 30
m i n u t e sa t3 7 ◦C. Cells were subsequently ﬁxed with 3%
paraformaldehyde, washed twice in PBS, and incubated
in crystal violet dye for 15 minutes. Wells were washed
thoroughly with water and the violet dye was extracted
with 10% SDS solution. Absorbance was measured using
a TECAN SPECTRAFluor spectrophotometer at 595nm
and relative adhesion was compared to cells attached to
nd-blotto.
Integrin-blocking adhesion assays were performed ac-
cording to the procedure above, but the cells were incu-
bated with a functional integrin-blocking antibody for 30
minutes at 37◦C, with vortexing every 5 minutes, prior to
plating.
Immunohistochemistry
Tubulin, F-actin, and osteopontin were localized in
hMSCculturedonglasscoverslipsaspreviouslydescribed
[19]. Brieﬂy, primary antibodies or phalloidin (diluted
1:200 in PBS) were added for 1 hour to cells ﬁxed in
3% paraformaldehyde and blocked with PBS/1%BSA.
Secondary antibodies conjugated to ﬂuorescein or rho-
damine (Jackson Immuno Research, Inc, West Grove, Pa)
were added for 1 hour, then coverslips were mounted us-
ing Prolong antifade medium (Molecular Probes, Eugene,
Ore). Cells were visualized with a Nikon TE2000-S in-
verted ﬂuorescence/phase contrast microscope equipped
with a digital SPOT camera.
Westernblotanalysis
Proteins were separated by 8% SDS-PAGE and trans-
ferred to Immobilon-P transfer membranes from Milli-
pore (Bedford, Mass) and processed for immunoblotting
as previously described [20]. Processed membranes in-
cubated with primary antibody overnight were then in-
cubated with secondary goat anti-rabbit IgG-HRP from
Pierce Biotechnology (Rockford, Ill) and exposed to Un-
Blot Chemiluminescent reagent from Pierce Biotechnol-
ogy. Images were detected with a ChemiImager 4400 Gel
imaging system (Alpha Innotech, San Leandro, Calif).
Histologicalstainingofalkalinephosphataseactivity
andcalciumprecipitation
At days 4, 8, 12, and 16, cell cultures were assayed as
describedbelow.Forthedetectionofalkalinephosphatase
activity,asolutionofnaphtholAS-MXphosphateandfast
blue RR dissolved in distilled (d) H2O was poured into
wells of a 24-well plate according to the manufacturer’s
instructions contained in Sigma Kit #85. Cellular speci-
mens were scored according to the quantity and intensity
of the precipitated dye. For the detection of a calcium-
phosphate-containing matrix, cell layers were stained by
the von Kossa method [21]. Specimens were ﬁxed in
3% paraformaldhyde for 30 minutes. and subsequently
washed twice in dH2O and incubated in the dark with 5%
silver nitrate solution for 10 minutes. Afterwards, the cell
layers were washed thoroughly with dH2O and then ex-
posed to bright sunlight for 1 hour. Cellular specimens
were scored according to the quantity and size of precipi-
tated granules.
Calciumassay
Specimens were washed twice with PBS and extracted
oﬀ a well of a 24-well plate in 0.5 N HCl. Accumulated
calcium was removed from the cellular component by
shaking for 5 hours at 4◦C, followed by centrifugation at
2,000g for 10 minutes. The consequent supernatant was
utilized for calcium determination according to the man-
ufacturer’sinstructionscontainedinSigmaKit#587.Total
calcium was calculated from standard solutions prepared
in parallel and expressed as ng/well after absorbance at
575nm was measured.
Mineralizedbone:Fouriertransform
infrared(FTIR)analysis
The presence of apatite in cell matrix was detected by
FTIR of ground powders. Cell layers, collected in 50mM
ammonium bicarbonate (pH 8.0), were lyophilized and
analyzed as potassium bromide (KBr) pellets on a Bio-
Rad FTS 40-A spectrometer (Bio-Rad, Cambridge, Mass,
USA). The data was collected under nitrogen purge,
and the spectral baseline corrected and analyzed using
GRAMS/386 software (Galactic Industries, Salem, NH,
USA) as previously described [22]. The mineral content
is calculated based on the spectrally derived mineral-
to-matrix ratio (the integrated areas of the phosphate2004:1 (2004) HMSC Diﬀerentiation on Extracellular Matrix 27
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Figure 1. Static 30-minute assays of hMSC adhesion to puriﬁed extracellular matrix proteins. Adherent cells were stained with crystal
violet, then solubilized in SDS and absorbance determined at 595nm. Values represent mean ± standard deviation (n = 5).
absorbance (900–1200cm−1) and protein amide I band
(1585–1720cm−1)).
Reversetranscriptase-polymerasechainreaction
RNA was isolated from 10 × 108 hMSC cultured for
eight days on tissue culture plastic in the presence or ab-
sence of OS, or on COL I, or VN in control media. As
a positive control for diﬀerentiation, RNA was isolated
from 10 × 108 human osteoblasts cultured for eight days.
Total RNA was isolated using the RNeasy mini kit (Qi-
agen, Valencia, Calif). RT-PCR was performed with the
OneStep RT-PCR Kit (Qiagen) and a 96-well thermal cy-
cler (MJ Research, Waltham, Mass) using the primers
listed in Table 1, which were obtained from [7, 23]. One
microgram of template RNA was used per reaction. The
reverse transcription step ran for 30 minutes at 50◦C, fol-
lowed by PCR activation for 15 minutes at 95◦C. Thirty
ampliﬁcation cycles were run, consisting of one minute
denaturation at 94◦C, one minute of annealing at 58◦C,
and one minute of extension at 72◦C. Final extension
was allowed to run 10 minutes at 72◦C. Reaction prod-
ucts were separated by gel electrophoresis using a 2%
agarose gel. Bands were visualized by UV illumination
of ethidium-bromide-stained gels and captured using a
ChemiImager4400Gelimagingsystem(AlphaInnotech).
RESULTS
HMSCadhesiontopuriﬁedECMproteins
To assess the contribution of extracellular matrix pro-
teins to the osteogenic diﬀerentiation of hMSC, we ﬁrst
examined the ability of these cells to adhere to ECM pro-
teins found in bone marrow. In 30-minute adhesion as-
says, we found that ﬁbronectin, COL I, COL IV, and
vitronectin supported approximately 6- to 8-fold greater
static adhesion compared to the negative control (nd-
blotto)orlaminin-1(Figure 1).Approximately75%–80%
of cells adhered to ﬁbronectin, as assessed by visual in-
spection before and after washing steps. Adhesion to the
indicated ECM proteins was blocked more than 90% by
antibodies against the following integrins: COL I, α1a n d
β1; COL IV, α1a n dβ1; FN, α5a n dβ1; and VN, αVa n d
β3 (not shown).
HMSCmorphologyandarrangementofmicrotubules
andactinﬁlaments
We observed culture medium-dependent diﬀerences
in overall cellular morphology in cells plated on puri-
ﬁed ECM proteins for up to 16 days. For example, cells
plated on vitronectin (VN) in control medium had a
more linear arrangement of the microtubule cytoskele-
ton than those plated on OS medium (Figures 2a and
2b). Cells plated on COL I also showed these morpho-
logicaldiﬀerences,anddisplayedarearrangementofactin
bundles when cultured in OS medium (Figures 2c and
2d). We also observed extensive infoldings of the plasma
membrane, resulting in the appearance of an array of
ﬁlopodia- and lamellopodia-like structures in OS-treated
cells. Yet these projections lacked organized microtubules
(Figure 2b), actin ﬁlaments (Figure 2d), and focal adhe-
sions (not shown). This eﬀect was seen in cells plated on
all substrates tested, including glass, and appeared to be
an eﬀect of the OS-media rather than the substrates. No
statistical diﬀerence in overall surface area was found be-
tween control or OS-treated cells on any substrate (not
shown).
BindingtovitronectinandCOLIstimulates
osteogenicdifferentiationofhMSC
We assessed osteogenic diﬀerentiation of our cultures
by a number of criteria. First, we determined the min-
eral to matrix ratio of the secreted ECM, a hallmark of
ossiﬁcation (Table 2). We found that culturing hMSC on
puriﬁed VN or COL I, even in the absence of OS stim-
ulants, is suﬃcient to induce mineralization, and hence
osteogenic diﬀerentiation, after only 16 days. When com-
pared to control cultures of fully diﬀerentiated osteoblasts
(Figure 3a), the Fourier transform infrared (FTIR) spec-
troscopic assessment of mineral content from hMSC cul-
turedonCOLI(Figure 3c)andVN(Figure 3d)agreewell,
while the spectrum from cells plated on tissue culture
plastic in control medium lacks a signiﬁcant phosphate28 Roman M. Salasznyk et al 2004:1 (2004)
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Figure 2. Rearrangement of microtubules and actin ﬁlaments in OS-treated cells. HMSC were plated on VN for 16 days in control
(a) or OS-containing medium (b), or on COL I for 16 days in control medium (c) or in OS medium (d) then ﬁxed and stained for
tubulin using primary antitubulin antibody (a) and (b) or for F-actin using TRITC-phalloidin (c) and (d). Bar = 200 micrometers.
Table 2.OsteogenicdiﬀerentiationofhMSCplatedonindicated
substrates for 16 days, as assessed by indicated measurements
of mineral to matrix ratio. By comparison, fully diﬀerentiated
osteoblasts cultured on tissue culture plastic for 21 days have a
ratio of approximately 5.4.
HMSC plated on substrate/medium M i n e r a lt om a t r i xr a t i o
Tissue culture plastic/DMEM 1.662
Tissue culture plastic/OS 1.515
Collagen I/DMEM 1.763
Collagen I/OS 2.372
Vitronectin/DMEM 2.767
Vitronectin/OS 2.761
peak (Figure 3b). Mineral to matrix ratios of diﬀerenti-
ated osteoblasts are approximately 5.4 after 21 days in cul-
ture(A.Boskey,unpublishedobservation)suggestingthat
VN and COL I induce proper mineralization of hMSC
matrix in the absence of OS media, and that this miner-
alization is approximately half that of mature osteoblasts
after only 16 days.
Our mineralization data strongly support our sup-
position that ECM stimuli alone play an important role
in inducing osteogenesis of hMSC. Over the same time
course, we found that COL I and VN also supported
calciﬁcation of the matrix, as assessed by measurements
of total calcium [24]( Figure 4) and by the von Kossa sil-
ver nitrate staining method for secreted calcium salt [21]
(Figure 5).
Immunohistochemicallocalization(Figure 6aand6b)
and western blotting (Figure 6b) of the early osteogenic
marker protein osteopontin revealed distinct accumula-
tion of this protein in cells plated on COL I and VN; this
accumulationwasnotseenincellsplatedontissueculture
plastic (Figure 6b,l a n e1 ) .
Though not speciﬁc for osteoblasts, expression of al-
kaline phosphatase (AP) is a well-established marker for
diﬀerentiation along the osteogenic pathway [6, 25]. Plat-
ing cells in control medium on COL I and VN for 16
days increased AP activity relative to control cells plated
on glass; addition of traditional osteogenic supplements
exacerbated these eﬀects (Figure 7). In the control group,
approximately40%ofcellsstainedpositive forAPactivity
by day 16, while at least 80% of cells in the OS group were
positive by day 16 (data not shown).
Collectively, these data suggest that plating cells on
COL I or VN induces osteogeneic diﬀerentiation of
hMSC. To conﬁrm our ﬁndings, we performed RT-PCR
analysis for three osteogenic marker genes: COL I, osteo-
pontin, and alkaline phosphatase. Our results (Figure 8)
demonstrate that COL I and VN support expression of all2004:1 (2004) HMSC Diﬀerentiation on Extracellular Matrix 29
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Figure 3. Spectroscopic analysis of apatite in hMSC cultures. For comparison, the proﬁle for matrix secreted by mature osteoblasts
cultured for 21 days is shown in (a). The hMSC were plated under the indicated conditions (b), (c), and (d) for 16 days, then the
matrix was collected and analyzed by FTIR.
three genes in hMSC after eight days in culture. In par-
ticular, osteopontin expression was highest in cells plated
on VN (lane 4). In addition, COL I expression was great-
est in cells plated on COL I (lane 3). Fully diﬀerentiated
osteoblasts (lane 5) expressed relatively high amounts of
all three genes tested, consistent with their diﬀerentiated
phenotype.
DISCUSSION
Our data demonstrate a strong and rapid (30 min-
utes) adhesive interaction between hMSC and four of the
ﬁve major ECM proteins found in bone marrow (COL
I, VN, COL IV, ﬁbronectin). The lack of rapid adhesion
to laminin-1 may be explained by the reported absence
of the laminin receptor α3β1 integrin in preosteoblasts
[33]. The hMSC do attach speciﬁcally to laminin-1, but
only after two hours (not shown). Gronthos et al [33]
have demonstrated that stromal stem cells proliferate on
all ECM proteins we tested, including laminin-1, using a
14-day colony-forming assay. We have observed that plat-
ing hMSC on puriﬁed ECM proteins, including laminin-
1, supports growth for atleast 16 days. It is thereforelikely
that all ECM proteins we tested play a role in some stage
of osteogenesis.
Some diﬀerences between our results and those for
stromal stem cells and osteoblasts are noteworthy. For ex-
ample, we ﬁnd little role for ﬁbronectin in stimulating os-
teogenic diﬀerentiation, beyond activation of AP activity
(not shown). However, Damsky and colleagues [26, 27,
28] have demonstrated a role for ﬁbronectin during cal-
varialosteoblastdiﬀerentiationinvitro.Yuetal[29]iden-
tiﬁed increased ﬁbronectin expression during the chon-
drogenesis phase of bone formation in vivo. Fibronectin
expression varies signiﬁcantly during the time course of
mesenchymal condensation, chondrogenesis, and bone
formation, and is expressed as splice variants. It is there-
fore possible that the window of diﬀerentiation we have
observed with hMSC represents a stage largely indepen-
dentofﬁbronectin’seﬀects.Alternatively,therequirement30 Roman M. Salasznyk et al 2004:1 (2004)
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Figure 4. The hMSC produce a calciﬁed matrix when plated
on COL I and VN. (a) Cells were plated on tissue culture plas-
tic (CTL), COL I (C-I), or vitronectin (VN) in control medium
(DMEM)ormediasupplementedwithosteogeneicsupplements
(OS) for the indicated time, then total calcium in each well was
determined using a colorimetric assay.
Table 3. Values of total calcium in each well for all samples at
day 16. The values were determined using a colorimetric assay.
HMSC plated on substrate/medium Total calcium (ng/well)
Tissue culture plastic/DMEM 3.204 ±0.73
Tissue culture plastic/OS 669.73 ±20.06
Vetronectin/DMEM 65.79 ±4.56
Vetronectin/OS 751.21 ±25.32
Collagen I/DMEM 54.43 ±6.14
Collagen I/OS 684.22 ±23.38
Collagen IV/DMEM 25.94 ±2.45
Collagen IV/OS 645.92 ±21.87
Fibronectin/OS 663.06 ±18.35
Laminin-1/OS 613.47 ±15.21
for ﬁbronectin may be tissue speciﬁc, such that calvar-
ial osteoblasts require ﬁbronectin while bone-marrow-
derived stem cells do not.
COL I has been reported to induce calciﬁcation of
stromal cell matrix after 3 weeks [16] while we ﬁnd that
both VN and COL I support the greatest increase in min-
eral to matrix ratio, calcium deposition, and osteopon-
tin/osteocalcin secretion. These increases are observed
in both control media and OS-containing media; as ex-
pected, the eﬀects are signiﬁcantly increased in OS me-
dia (Figure 4 and Table 3), suggesting that contact with
ECM alone induces diﬀerentiation but also enhances the
sensitivity to OS media. The diﬀerentiation we observe in
hMSC occurs within 16 days rather than 21 days, as re-
ported for stromal cells. These results may be explained
by the fact that stromal cells and hMSC, while being
clearly similar, are isolated using diﬀerent stem cell mark-
ers [2, 30, 31, 32]. From the combined results from both
cell types we conclude that multiple ECM proteins may
provide a suitable substrate for the attachment of hMSC
to the underlying matrix, but that signaling through the
COL I receptor α1β1 integrin and the VN receptor αVβ3
integrin plays the most signiﬁcant role in promoting os-
teogenesis. Incubation of preosteoblasts with a function-
blocking antibody against the integrin α1 subunit inhibits
matrix mineralization [33], further implicating α1β1a sa
signiﬁcant player in this process.
T h eh M S Ch a v eb e e nr e p o r t e dt ou n d e r g oam o r -
phological transition from an elongated, spindle shape to
a cuboidal shape during OS-induced diﬀerentiation [3].
Ourresultssupportthisobservation,andbasedonourex-
amination of the microtubule and actin cytoskeleton, we
conclude that OS components induce dramatic remod-
eling of the entire cytoskeletal network. A drop in par-
allel microtubule bundles and actin stress ﬁbers in OS-
treated cells, accompanied by extensive infolding of the
plasma membrane, suggests that cells are transitioning
from a tightly adhesive to a more loosely adherent pheno-
type.ThetotalsurfaceareaincontrolandOS-treatedcells
did not diﬀer signiﬁcantly (not shown), so cell spread-
ing appears to be not directly aﬀected. But the absence of
focal complexes or focal adhesions in these OS-induced
projections suggests that they are not ﬁlopodia or lamel-
lopodia, and that OS-treated cells are not motile. Inter-
estingly, however, we found that cells plated on VN or
COL I in control medium lacked these projections and
yet underwent the initial stages of ossiﬁcation, suggest-
ing that hMSC may retain some migration ability in the
early phases of diﬀerentiation. This raises an additional
concern regarding the use of OS components for in vivo
application of hMSC. In particular, this could have im-
portantimplicationsfortissueengineeringofbone,where
proper organization of osteoblasts in implants is essential,
and may require stem cell migration following polymer
seeding [34, 35]. Our results suggest that OS components
may not be necessary for proper diﬀerentiation of hMSC
in engineered bone.
Our diﬀerentiation data suggest that adhesion to pu-
riﬁed VN, in addition to COL I, is a potent inducer of
hMSC osteogenesis. However, it is certain that osteogene-
sis requires contact with COL I. This in turn suggests that
VN and COL I may act cooperatively during diﬀerentia-
tion. While the αvβ3 integrin binds to RGD sites in COL
I, these sites are cryptic and are only exposed after prote-
olytic processing of native COL I [34]. The αvβ3 integrin
also binds to the RGD sequence in osteopontin [9, 36],
and thus may participate in later stages of diﬀerentiation,
following osteopontin expression. We ﬁnd expression of
COL I in VN cultures at days 12 and 16 (not shown).
The presence of both VN and COL I in the “VN” sam-
ples, especially at later time points, may engage multiple2004:1 (2004) HMSC Diﬀerentiation on Extracellular Matrix 31
(a) (b) (c)
(d) (e) (f)
Figure 5. HMSC plated on COL I and vitronectin react positively by von Kossa staining. Cells were plated on tissue culture plastic
(a), (b); COL I (c), (d); or VN (e), (f) in control medium (a), (c), and (e) or in OS supplemented medium (b), (d), and (f) for 16
days, then treated with silver nitrate solution. Presence of precipitated silver grains indicates the presence of calcium phosphate in the
culture well (10× magniﬁcation).
50µm
(a) (b)
61.0 kd
12 3
(c)
Figure 6. HMSC plated on COL I and VN express osteopontin. (a) and (b) Immunohistochemical staining of osteopontin in hMSC
on day 16. Cells plated on COL I in DMEM (a) or on VN in DMEM (b) exhibit intracellular staining and deposits of osteopontin in
the extracellular space. Arrows indicate concentrated aggregates of osteopontin. Bar in (a) = 50µm, in (b) = 200µm. (c) Western blot
of cells cultured for eight days in control medium on tissue culture plastic (lane 1), COL I (lane 2), or VN (lane 3), and probed for
osteopontin expression.
integrin receptors simultaneously and thereby activate
a host of signaling pathways, which in turn leads to
enhanced matrix mineralization. Thus, our data suggest
a model wherein contact with COL I stimulates hMSC ex-
pression of osteogenic genes directly, while contact with
VN may stimulate expression of COL I; both α1β1a n d
αvβ3 integrins contribute to osteogenic diﬀerentiation via
distinct mechanisms.
Exactly how ECM contact inﬂuences expression of
osteogeneic genes is not known. However, considerable32 Roman M. Salasznyk et al 2004:1 (2004)
(a) (b)
(c) (d)
Figure 7. HMSC plated on COL I or VN express alkaline phosphatase activity. Cells were plated on tissue culture plastic (a), COL
I (c), and vitronectin (d) in control media for 16 days then stained for alkaline phosphatase activity. Cultures were plated on tissue
culture plastic in osteogenic supplement medium (b) as a positive control. Cells expressing alkaline phosphatase appear dark in phase
contrast micrographs (10× magniﬁcation).
Alkaline phosphatase
12 3 4 5
COL I
Osteopontin
Glyceraldehyde-3-phosphate
dehydrogenase
Figure 8. HMSC plated on COL I or VN express osteogenic genes. Indicated genes were ampliﬁed by RT-PCR from RNA isolated
from hMSC plated for eight days in control medium on tissue culture plastic (lane 1), OS medium on tissue culture plastic (lane 2),
control medium on COL I (lane 3), or control medium on VN (lane 4). As a positive control, RNA from eight-day cultures of fully
diﬀerentiated osteoblasts was run in parallel (lane 5).
data implicates a role for the transcription factor Runx2/
CBFA-1 in controlling osteogenic gene expression [37,
38]. Activation of this transcription factor occurs via
serine phosphorylation by extracellular regulated kinase
1/2(ERK1/2)[39],whichisatargetofbothgrowthfactor
receptors and integrin signaling pathways. Thus integrin-
ECM contact may initiate a signaling cascade through
ERK 1/2 that leads to activation of Runx2/CBFA-1. The2004:1 (2004) HMSC Diﬀerentiation on Extracellular Matrix 33
exact makeup of this signaling pathway has yet to be de-
termined, but multiple studies have linked integrin bind-
ingtoERK1/2activationinothercelltypes.Theresultsof
this study suggest that at least two distinct ECM proteins,
and their corresponding integrin receptors, stimulate os-
teogenic diﬀerentiation without soluble OS factors, and
strongly suggest that integrin signaling pathways directly
control hMSC diﬀerentiation.
REFERENCES
[1] JaiswalRK,JaiswalN,BruderSP,MbalavieleG,Mar-
shak DR, Pittenger MF. Adult human mesenchymal
stem cell diﬀerentiation to the osteogenic or adi-
pogenic lineage is regulated by mitogen-activated
protein kinase. JB i o lC h e m .2000;275(13):9645–
9652.
[2] Pittenger MF, Mackay AM, Beck SC, et al. Multilin-
eage potential of adult human mesenchymal stem
cells. Science. 1999;284(5411):143–147.
[3] Jaiswal N, Haynesworth SE, Caplan AI, Bruder
SP. Osteogenic diﬀerentiation of puriﬁed, culture-
expanded human mesenchymal stem cells in vitro.
JC e l lB i o c h e m .1997;64(2):295–312.
[ 4 ]M a c k a yA M ,B e c kS C ,M u r p h yJ M ,B a r ryF P ,C h i c h -
ester CO, Pittenger MF. Chondrogenic diﬀerenti-
ation of cultured human mesenchymal stem cells
from marrow. Tissue Eng. 1998;4(4):415–428.
[5] Bruder SP, Jaiswal N, Haynesworth, SE. Growth ki-
netics, self-renewal, and the osteogenic potential of
puriﬁed human mesenchymal stem cells during ex-
tensive subcultivation and following cryopreserva-
tion. JC e l lB i o c h e m .1997;64(2):278–294.
[6] Aubin JE. Advances in the osteoblast lineage.
Biochem Cell Biol. 1998;76(6):899–910.
[7] Doi M, Nagano A, Nakamura Y. Genome-wide
screening by cDNA microarray of genes associated
with matrix mineralization by human mesenchymal
stem cells in vitro. Biochem Biophys Res Commun.
2002;290(1):381–390.
[8] Higuchi C, Myoui A, Hashimoto N, et al. Contin-
uous inhibition of MAPK signaling promotes the
early osteoblastic diﬀerentiation and mineralization
of the extracellular matrix. JB o n eM i n e rR e s .2002;
17(10):1785–1794.
[9] Cheng SL, Lai CF, Fausto A, et al. Regulation of
alphaVbeta3 and alphaVbeta5 integrins by dexam-
ethasone in normal human osteoblastic cells. JC e l l
Biochem. 2000;77(2):265–276.
[10] Ng PC, Lam CW, Wong GW, et al. Changes in
markers of bone metabolism during dexamethasone
treatment for chronic lung disease in preterm in-
fants. Arch Dis Child Fetal Neonatal Ed. 2002;86(1):
F49–F54.
[11] Aubin JE. Regulation of osteoblast formation and
function. Rev Endocr Metab Disord. 2001;2(1):81–
94.
[12] Candeliere GA, Liu F, Aubin JE. Individual os-
teoblasts in the developing calvaria express diﬀerent
gene repertoires. Bone. 2001;28(4):351–361.
[13] Bortell R, Barone LM, Tassinari MS, Lian JB, Stein
GS. Gene expression during endochondral bone de-
velopment: evidence for coordinate expression of
transforming growth factor beta 1 and collagen type
I. JC e l lB i o c h e m .1990;44(2):81–91.
[14] Pace JM, Chitayat D, Atkinson M, Wilcox WR,
Schwarze U, Byers PH. A single amino acid substi-
tution (D1441Y) in the carboxyl-terminal propep-
tide of the proalpha1(I) chain of type I collagen re-
sults in a lethal variant of osteogenesis imperfecta
with features of dense bone diseases. JM e dG e n e t .
2002;39(1):23–29.
[15] Aszodi A, Bateman JF, Gustafsson E, Boot-Handford
R, Fassler R. Mammalian skeletogenesis and extra-
cellular matrix: what can we learn from knockout
mice? Cell Struct Funct. 2000;25(2):73–84.
[16] Mizuno M, Kuboki Y. Osteoblast-related gene ex-
pression of bone marrow cells during the osteoblas-
tic diﬀerentiation induced by type I collagen. J
Biochem (Tokyo). 2001;129(1):133–138.
[17] Xiao G, Wang D, Benson MD, Karsenty G,
Franceschi RT. Role of the alpha2-integrin in
osteoblast-speciﬁc gene expression and activation of
the Osf2 transcription factor. JB i o lC h e m .1998;
273(49):32988–32994.
[18] Schwartz MA, Ginsberg MH. Networks and
crosstalk: integrin signalling spreads. Nat Cell Biol.
2002;4(4):E65–E68.
[19] Plopper GE, Domanico SZ, Cirulli V, Kiosses WB,
Quaranta V. Migration of breast epithelial cells on
Laminin-5: diﬀerential role of integrins in normal
and transformed cell types. Breast Cancer Res Treat.
1998;51(1):57–69.
[20] Plopper GE, McNamee HP, Dike LE, Bojanowski
K, Ingber DE. Convergence of integrin and growth
factor receptor signaling pathways within the focal
adhesion complex. Mol Biol Cell. 1995;6(10):1349–
1365.
[21] Bills CE, Eisenberg H, Pallante SL. Complexes of or-
ganic acids with calcium phosphate: the von Kossa
stain as a clue to the composition of bone mineral.
Johns Hopkins Med J. 1971;128(4):194–207.
[22] Kato Y, Boskey A, Spevak L, Dallas M, Hori
M, Bonewald LF. Establishment of an osteoid
preosteocyte-like cell MLO-A5 that spontaneously
mineralizes in culture. JB o n eM i n e rR e s .2001;16(9):
1622–1633.
[23] Frank O, Heim M, Jakob M, et al. Real-time quanti-
tative RT-PCR analysis of human bone marrow stro-
mal cells during osteogenic diﬀerentiation in vitro. J
Cell Biochem. 2002;85(4):737–746.
[24] Kessler G, Wolfman M. An automated proce-
dure for the simultaneous determination of cal-
cium and phosphorus. Clin Chem. 1964;10:686–
703.34 Roman M. Salasznyk et al 2004:1 (2004)
[25] Christenson RH. Biochemical markers of bone
metabolism: an overview. Clin Biochem. 1997;30(8):
573–593.
[26] Globus RK, Moursi A, Zimmerman D, Lull J,
Damsky C. Integrin-extracellular matrix interac-
tions in connective tissue remodeling and os-
teoblast diﬀerentiation. ASGSB Bull. 1995;8(2):19–
28.
[27] Moursi AM, Globus RK, Damsky CH. Interac-
tions between integrin receptors and ﬁbronectin are
required for calvarial osteoblast diﬀerentiation in
vitro. JC e l lS c i .1997;110(pt 18):2187–2196.
[28] Moursi AM, Damsky CH, Lull J, et al. Fibronectin
regulates calvarial osteoblast diﬀerentiation. JC e l l
Sci. 1996;109(pt 6):1369–1380.
[29] Yu YM, Becvar R, Yamada Y, Reddi AH. Changes
in the gene expression of collagens, ﬁbronectin,
integrin and proteoglycans during matrix-induced
bone morphogenesis. Biochem Biophys Res Com-
mun. 1991;177(1):427–432.
[30] Conget PA, Minguell JJ. Phenotypical and func-
tional properties of human bone marrow mesenchy-
mal progenitor cells. JC e l lP h y s i o l .1999;181(1):67–
73.
[ 3 1 ]G u oZ ,Y a n gJ ,L i uX ,e ta l .B i o l o g i c a lf e a t u r e so f
mesenchymal stem cells from human bone marrow.
Chin Med J (Engl). 2001;114(9):950–953.
[32] Majumdar MK, Thiede MA, Mosca JD, Moorman
M, Gerson SL. Phenotypic and functional compar-
ison of cultures of marrow-derived mesenchymal
stem cells (MSCs) and stromal cells. JC e l lP h y s i o l .
1998;176(1):57–66.
[ 3 3 ] G r o n t h o sS ,S i m m o n sP J ,G r a v e sS E ,R o b e y
PG. Integrin-mediated interactions between human
bone marrow stromal precursor cells and the extra-
cellular matrix. Bone. 2001;28(2):174–181.
[34] Davis GE. Aﬃnity of integrins for damagedextracel-
lular matrix: alpha v beta 3 binds to denatured col-
lagen type I through RGD sites. Biochem Biophys Res
Commun. 1992;182(3):1025–1031.
[35] Shea LD, Wang D, Franceschi RT, Mooney DJ. En-
gineered bone development from a pre-osteoblast
cell line on three-dimensional scaﬀolds. Tissue Eng.
2000;6(6):605–617.
[36] Caltabiano S, Hum WT, Attwell GJ, et al. The
integrin speciﬁcity of human recombinant os-
teopontin. Biochem Pharmacol. 1999;58(10):1567–
1578.
[37] Franceschi RT. The developmental control of
osteoblast-speciﬁc gene expression: role of speciﬁc
transcriptionfactorsandtheextracellularmatrixen-
vironment. Crit Rev Oral Biol Med. 1999;10(1):40–
57.
[38] Franceschi RT, Xiao G. Regulation of the osteoblast-
speciﬁc transcription factor, Runx2: responsiveness
to multiple signal transduction pathways. JC e l l
Biochem. 2003;88(3):446–454.
[39] Xiao G, Gopalakrishnan R, Jiang D, Reith E, Ben-
son MD, Franceschi RT. Bone morphogenetic pro-
teins, extracellular matrix, and mitogen-activated
protein kinase signaling pathways are required for
osteoblast-speciﬁc gene expression and diﬀerentia-
tion in MC3T3-E1 cells. JB o n eM i n e rR e s .2002;
17(1):101–110.
∗ Corresponding author.
E-mail: ploppg@rpi.edu
Fax: +1 518 276 2162; Tel: +1 518 276 8288